Holen Sie sich die Stockscreener-App
44.55
0.09%
-0.04
Schlusskurs vom Vortag:
$44.59
Offen:
$44.6
24-Stunden-Volumen:
1.19M
Relative Volume:
0.40
Marktkapitalisierung:
$37.07B
Einnahmen:
$27.43B
Nettoeinkommen (Verlust:
$1.27B
KGV:
28.14
EPS:
1.5829
Netto-Cashflow:
$1.01B
1W Leistung:
-5.81%
1M Leistung:
+3.97%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$44.03
$45.43
1-Wochen-Bereich:
$43.57
$47.88
52-Wochen-Spanne:
$38.50
$47.99
Medline Inc Stock (MDLN) Company Profile
Compare MDLN vs ISRG, BDX, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDLN
Medline Inc
|
44.55 | 37.11B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
ISRG
Intuitive Surgical Inc
|
485.84 | 169.97B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
175.89 | 50.58B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
79.20 | 38.58B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
252.55 | 35.80B | 5.40B | 1.49B | 1.78B | 10.12 |
Medline Inc Stock (MDLN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-05 | Eingeleitet | Tigress Financial | Buy |
| 2026-01-21 | Bestätigt | BTIG Research | Buy |
| 2026-01-12 | Eingeleitet | Citigroup | Buy |
| 2026-01-12 | Eingeleitet | Deutsche Bank | Hold |
| 2026-01-12 | Eingeleitet | Evercore ISI | Outperform |
| 2026-01-12 | Eingeleitet | Goldman | Buy |
| 2026-01-12 | Eingeleitet | JP Morgan | Overweight |
| 2026-01-12 | Eingeleitet | Jefferies | Buy |
| 2026-01-12 | Eingeleitet | Leerink Partners | Outperform |
| 2026-01-12 | Eingeleitet | Mizuho | Outperform |
| 2026-01-12 | Eingeleitet | Morgan Stanley | Overweight |
| 2026-01-12 | Eingeleitet | Piper Sandler | Overweight |
| 2026-01-12 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-12 | Eingeleitet | Robert W. Baird | Outperform |
| 2026-01-12 | Eingeleitet | Rothschild & Co Redburn | Neutral |
| 2026-01-12 | Eingeleitet | Stifel | Buy |
| 2026-01-12 | Eingeleitet | TD Cowen | Buy |
| 2026-01-12 | Eingeleitet | Truist | Buy |
| 2026-01-12 | Eingeleitet | UBS | Buy |
| 2026-01-12 | Eingeleitet | Wells Fargo | Equal Weight |
| 2026-01-12 | Eingeleitet | William Blair | Outperform |
| 2026-01-12 | Eingeleitet | Wolfe Research | Outperform |
Alle ansehen
Medline Inc Aktie (MDLN) Neueste Nachrichten
FDA Flags Serious Safety Fire Risks In Medline Homecare Beds - Benzinga
Is It Too Late To Consider Medline (MDLN) After Its Recent Share Price Rally? - Yahoo Finance
Medline stock pops 40% in first trading session after company raises $6.3 billion in 2025's biggest IPO - AOL.com
Evaluating Medline (MDLN) After Recent Share Price Momentum And A 31.1x P/E Multiple - Sahm
Medline Inc. (MDLN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Medline Inc.Class A common stock (NQ: MDLN - FinancialContent
MDLN Medline Inc. Feb 2026 Tigress Financial Initiates Coverage with Buy - Meyka
Tigress Financial initiates Medline stock with Buy rating, $55 target By Investing.com - Investing.com Nigeria
Tigress Financial initiates Medline stock with Buy rating, $55 target - Investing.com
Medline (NASDAQ:MDLN) Now Covered by Analysts at Tigress Financial - MarketBeat
Tigress Initiates Medline at Buy With $55 Price Target - marketscreener.com
How the Largest IPO of 2025 Could Be Healthy for Your Portfolio - The Motley Fool
Wash. Justices Won't Hear Medline's $2.4M Refund Request - Law360
Medline CEO Jim Boyle talks record IPO and AI plans with hospitals - Crain's Chicago Business
Medline’s Jim Boyle talks record IPO, AI plans with hospitals - Modern Healthcare News
Medline to report fourth quarter and full year 2025 results on February 25, 2026 - GlobeNewswire
Is It Time To Reassess Medline (MDLN) After Its Recent Share Price Climb - Yahoo Finance
Medline Inc (MDLN) Shares Up 3.65% on Jan 22 - GuruFocus
Jim Cramer says Medline stock is unbelievable and recommends buying it - MSN
Jim Cramer Says Medline "Stock Is Unbelievable" And Recommends Buying It - Finviz
Jim Cramer Says Medline “Stock Is Unbelievable” And Recommends Buying It - Yahoo Finance
Medline Industries: Solid Physical Moat With Visible Earnings Growth Runway (NASDAQ:MDLN) - Seeking Alpha
Jim Cramer Recently Looked at These 25 Stocks - Insider Monkey
Is There An Opportunity In Medline (MDLN) After Recent DCF Valuation Results - Sahm
Pointcore Supply Chain Services members select Medline as distributor - Medline Newsroom
Ranpak expands packaging automation partnership with Medline - Packaging Insights
In face of uncertainty and tariffs, newly public Medline sticks to the old formula - Crain's Chicago Business
Ranpak and Medline deepen packaging automation collaboration - Yahoo Finance
Ranpak in Collaboration with Medline - Medical Device and Diagnostic industry
Medline Shares Climb as Analysts Launch Coverage After $7.2 Bill - GuruFocus
Medline Shares Climb as Analysts Launch Coverage After $7.2 Billion IPO - Yahoo Finance
Ranpak and Medline Partner to for High-Volume Distribution Operations From: Ranpak Corporation - Healthcare Packaging
Ranpak Holdings Corp. and Medline Partner to Advance Automation and Sustainable Packaging Across High-Volume Distribution Operations - marketscreener.com
Ranpak and Medline Partner to Advance Automation and Sustainable Packaging Across High-Volume Distribution Operations - Business Wire
Analysts Are Bullish on These Healthcare Stocks: Exagen (XGN), Medline, Inc. Class A (MDLN) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Medline, Inc. Class A (MDLN) and IDEAYA Biosciences (IDYA) - The Globe and Mail
Medline jumps as analysts bullish after 2025’s top IPO - The Daily Gazette
Medline Jumps as Analysts Bullish After 2025’s Top IPO - Bloomberg
Analysts initiate coverage on Medline after IPO, flag growth visibility and margin - Investing.com
Why Is Medline Stock Gaining Monday?Medline (NASDAQ:MDLN) - Benzinga
Analysts Say Medline Has The Secret Sauce For Sustained Growth - Sahm
Is Medline (MDLN) Fairly Priced After Recent Share Price Stability? - Yahoo Finance
Analysts initiate Medline with bullish ratings after blockbuster IPO - Reuters
TD Cowen initiates Medline stock with Buy rating on market share growth - Investing.com Nigeria
BTIG initiates coverage on Medline stock with Buy rating, $50 target By Investing.com - Investing.com South Africa
Wells Fargo & Company Begins Coverage on Medline (NASDAQ:MDLN) - MarketBeat
This Netflix Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Medline initiated with a Buy at BTIG - TipRanks
Goldman Sachs Initiates Coverage on Medline With Buy Rating, $49 Price Target - marketscreener.com
BMO Capital Initiates Coverage on Medline With Outperform Rating, $45 Price Target - marketscreener.com
JPMorgan Initiates Coverage on Medline With Overweight Rating, $50 Price Target - marketscreener.com
Finanzdaten der Medline Inc-Aktie (MDLN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Medline Inc-Aktie (MDLN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| GIC Private Ltd | 10% Owner |
Dec 18 '25 |
Buy |
29.00 |
12,586,206 |
364,999,974 |
27,241,378 |
| GIC Private Ltd | 10% Owner |
Dec 18 '25 |
Sale |
28.37 |
10,204,351 |
289,480,090 |
91,555,447 |
| TC Group VII S1, L.L.C. | 10% Owner |
Dec 18 '25 |
Sale |
29.00 |
19,136,333 |
554,953,657 |
145,924,924 |
| Carlyle Mozart Coinvestment Ho | 10% Owner |
Dec 18 '25 |
Sale |
29.00 |
19,136,333 |
554,953,657 |
145,924,924 |
| Carlyle Group Inc. | 10% Owner |
Dec 18 '25 |
Sale |
29.00 |
19,136,333 |
554,953,657 |
145,924,924 |
| Mozart Aggregator II LP | 10% Owner |
Dec 18 '25 |
Sale |
28.37 |
13,462,600 |
381,911,076 |
143,187,216 |
| Mills Andrew J. | Director |
Dec 18 '25 |
Buy |
29.00 |
2,586,206 |
74,999,974 |
2,586,206 |
| Mills Charles N. | Director |
Dec 18 '25 |
Buy |
29.00 |
2,579,310 |
74,799,990 |
2,441,379 |
2.78%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):